Carnyx Therapeutics, Ltd — Form C (Regulation Crowdfunding)
Carnyx Therapeutics, Ltd of INDIANAPOLIS, IN filed a Form C (Regulation Crowdfunding) with the SEC on 2025-12-03. Target raise $20K, up to $5.0M. Offered through Equifund Crowd Funding Portal Inc..
Offering
- Filed: 2025-12-03
- Form: C
- Accession: 0001640334-25-002246
- Target amount: $20K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 10,695
- Price: $1.8700
- Deadline: 2026-12-03
- Funding portal / intermediary: Equifund Crowd Funding Portal Inc.
- Intermediary file number: 007-00115
- Intermediary CRD: 000288900
Issuer
- CIK: 0002098209
- Website: https://www.carnyxtx.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2024-06-14
- Address: 1250 INDIANA AVE, INDIANAPOLIS, IN, 46202
- Employees: 0
Financials (as filed)
- Total assets (most recent): $1.8M
- Cash (most recent): $1.8M
- Net income (most recent): $-547K
- Short-term debt: $138K
- Long-term debt: $2.2M
People (6)
| Name | Role | Location |
|---|
| Mark Bell | Chief Development Officer | Atlanta, GA |
| Terry Butler | Chief Financial Officer | Las Vegas, NV |
| Elvin De Araujo | Chief Operating Officer and Director | INDIANAPOLIS, IN |
| Patrick Gunning | Chief Executive Officer | INDIANAPOLIS, IN |
| Patrick Gunning | Chief Executive Officer and Director | INDIANAPOLIS, IN |
| Mark Lindsay | Chief Innovation Officer and Director | INDIANAPOLIS, IN |
More